Title:
AIEGENS FOR CANCER CELLS AND GRAM-POSITIVE BACTERIA DISCRIMINATION AND KILLING
Document Type and Number:
WIPO Patent Application WO/2018/210334
Kind Code:
A1
Abstract:
AIE luminogens as theranostic agents may be used in photodynamic therapy to selectively detect and kill cancer cells and gram-positive bacteria. The theranostic agent can include a small molecule, organic compound capable of aggregation-induced emission and generation of reactive oxygen species upon exposure to white light. The theranostic agent may be used to selectively visualize and/or impair or stop the growth of cancer cells or Gram-positive bacteria in situ during a surgical procedure.
More Like This:
Inventors:
TANG BENZHONG (CN)
KANG MIAOMIAO (CN)
GU XINGGUI (CN)
KANG MIAOMIAO (CN)
GU XINGGUI (CN)
Application Number:
PCT/CN2018/087479
Publication Date:
November 22, 2018
Filing Date:
May 18, 2018
Export Citation:
Assignee:
UNIV HONG KONG SCI & TECH (CN)
International Classes:
C07D215/42; A61K31/438; A61K31/44; A61P31/04; A61P35/00; C07D213/30; C07D215/26; C09K11/06; G01N21/64
Domestic Patent References:
WO2015163817A1 | 2015-10-29 | |||
WO2016070854A1 | 2016-05-12 | |||
WO2016078603A1 | 2016-05-26 |
Attorney, Agent or Firm:
TEE & HOWE INTELLECTUAL PROPERTY ATTORNEYS (CN)
Download PDF:
Previous Patent: DEVICE FOR ABSORBING NEGATIVE PARTICLES
Next Patent: FILM LAYER DOPING METHOD, THIN FILM TRANSISTOR AND MANUFACTURING METHOD THEREFOR
Next Patent: FILM LAYER DOPING METHOD, THIN FILM TRANSISTOR AND MANUFACTURING METHOD THEREFOR